Baxter International Inc. $BAX Shares Acquired by Police & Firemen s Retirement System of New Jersey

Police & Firemen s Retirement System of New Jersey increased its holdings in shares of Baxter International Inc. (NYSE:BAX) by 4.9% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 77,419 shares of the medical instruments supplier’s stock after purchasing an additional 3,588 shares during the quarter. Police & Firemen s Retirement System of New Jersey’s holdings in Baxter International were worth $2,344,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of BAX. Zions Bancorporation National Association UT acquired a new stake in shares of Baxter International in the first quarter worth $27,000. Creative Financial Designs Inc. ADV boosted its position in Baxter International by 169.6% during the 2nd quarter. Creative Financial Designs Inc. ADV now owns 984 shares of the medical instruments supplier’s stock worth $30,000 after purchasing an additional 619 shares during the period. Atlantic Union Bankshares Corp acquired a new stake in Baxter International in the 2nd quarter valued at $48,000. MassMutual Private Wealth & Trust FSB raised its position in Baxter International by 40.1% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 2,831 shares of the medical instruments supplier’s stock valued at $86,000 after purchasing an additional 810 shares during the period. Finally, Whittier Trust Co. lifted its stake in shares of Baxter International by 82.2% during the second quarter. Whittier Trust Co. now owns 3,202 shares of the medical instruments supplier’s stock worth $97,000 after purchasing an additional 1,445 shares in the last quarter. 90.19% of the stock is owned by institutional investors and hedge funds.

Baxter International Stock Down 2.5%

Shares of NYSE:BAX opened at $17.71 on Thursday. Baxter International Inc. has a 12-month low of $17.40 and a 12-month high of $37.74. The company has a current ratio of 2.30, a quick ratio of 1.49 and a debt-to-equity ratio of 1.30. The firm has a market cap of $9.10 billion, a PE ratio of -59.02, a price-to-earnings-growth ratio of 0.73 and a beta of 0.57. The company has a fifty day simple moving average of $21.54 and a 200 day simple moving average of $25.79.

Baxter International (NYSE:BAX) last announced its quarterly earnings data on Thursday, October 30th. The medical instruments supplier reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.60 by $0.09. The company had revenue of $2.84 billion during the quarter, compared to analyst estimates of $2.88 billion. Baxter International had a negative net margin of 1.42% and a positive return on equity of 16.96%. The firm’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period last year, the business earned $0.80 EPS. Baxter International has set its Q4 2025 guidance at 0.520-0.570 EPS. FY 2025 guidance at 2.350-2.400 EPS. On average, equities research analysts anticipate that Baxter International Inc. will post 2.48 EPS for the current fiscal year.

Baxter International Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 2nd. Investors of record on Friday, November 28th will be issued a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, November 28th. Baxter International’s payout ratio is currently -6.06%.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on BAX shares. Evercore ISI lowered their target price on Baxter International from $31.00 to $24.00 in a research note on Thursday, October 30th. Barclays lowered their price objective on shares of Baxter International from $41.00 to $36.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Wall Street Zen cut shares of Baxter International from a “buy” rating to a “hold” rating in a research report on Saturday, August 2nd. Citigroup decreased their target price on shares of Baxter International from $26.00 to $21.00 and set a “neutral” rating for the company in a research note on Friday, October 31st. Finally, Stifel Nicolaus dropped their price target on shares of Baxter International from $25.00 to $22.00 in a research note on Friday, October 31st. Two investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Reduce” and an average price target of $23.70.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.